Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

These aren't for the faint of heart.

Ark simultaneously rebalanced its portfolio, adding names such as Palantir, SpaceX, and Cerebras while exiting positions ...

Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

Cathie Wood's ARK Invest continued rotating toward AI infrastructure, digital assets, fintech and next-generation healthcare ...

Don't worry, this post is spoiler-free.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Here are Cathie Wood’s latest moves and thoughts.